Hamlet BioPharma Feed

2026-03-06 18:31:37 Hamlet BioPharma AB (publ): Hamlet BioPharma signed a Letter of Intent to outline terms of a potential collaboration and a commercial agreement concerning Alpha 1H.

2026-02-23 10:00:00 Hamlet BioPharma AB (publ): Nature Microbiology publicerar banbrytande studie om icke-antibiotisk behandling av återkommande urinvägsinfektioner 4,07 MSEK

2026-02-13 09:00:00 Hamlet BioPharma AB (publ): Q2 INTERIM REPORT OCT - DEC 2025 5,30 SEK | +5,16% | 1,49 MSEK

2026-02-12 17:03:27 Hamlet BioPharma AB (publ): Nature Microbiology publishes the paper `'Targeted innate immune inhibition therapy compared with antibiotics for recurrent acute cystitis: a randomized, open-label phase 2 trial.'' 5,04 SEK | +1,82% | 0,38 MSEK

2026-02-11 10:30:00 Hamlet BioPharma AB (publ): Monthly investor meeting on the 13th of February when Hamlet BioPharma is releasing it's Q2 report 4,95 SEK | -2,37% | 0,23 MSEK

2026-02-03 10:15:00 Hamlet BioPharma AB (publ): Collaboration agreement between Hamlet BioPharma and Immunoforge in South Korea 5,39 SEK | +0,75% | 0,65 MSEK

2026-01-27 12:00:00 Hamlet BioPharma AB (publ): 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 𝗼𝗻 𝗡𝗼𝘃𝗲𝗹 𝗧𝗿𝗲𝗮𝘁𝗺𝗲𝗻𝘁𝘀 𝗳𝗼𝗿 𝗜𝗻𝗳𝗲𝗰𝘁𝗶𝗼𝗻𝘀 𝗮𝗻𝗱 𝗖𝗮𝗻𝗰𝗲𝗿 5,37 SEK | -2,36% | 0,53 MSEK

2026-01-16 14:00:00 Hamlet BioPharma AB (publ): Invitation to digital meeting focusing on novel strategies for treating bacterial infections without antibiotics 5,74 SEK | -0,69% | 0,50 MSEK

2025-12-18 14:30:00 Hamlet BioPharma AB (publ): The HAMLET project featured in Cancerfonden's Christmas Campaign 5,28 SEK | +2,52% | 0,20 MSEK

2025-12-04 13:00:40 Hamlet BioPharma AB (publ): Kommuniké från årsstämma i Hamlet BioPharma AB och efterföljande styrelsemöte 5,12 SEK | +4,07% | 0,12 MSEK

2025-11-14 13:00:00 Hamlet BioPharma AB (publ): FDA ger Hamlet BioPharma pivotal status för avgörande Fas III-studie i blåscancer 5,32 SEK | +10,49% | 3,12 MSEK

2025-11-14 09:00:00 Hamlet BioPharma AB (publ): Q1 INTERIM REPORT JULY - SEPT 2025 5,32 SEK | +10,49% | 3,12 MSEK

2025-11-13 10:00:00 Hamlet BioPharma AB (publ): Hamlet BioPharma bjuder in till digitalt investerarmöte den 14 november 12.00 4,82 SEK | +3,77% | 0,96 MSEK

2025-11-12 10:00:00 Hamlet BioPharma AB (publ): Ny styrelsesammansättning stärker Hamlet BioPharma inför kommersialiseringsfas 4,64 SEK | -9,02% | 1,94 MSEK

2025-11-10 09:00:00 Hamlet BioPharma AB (publ): Hamlet BioPharma Receives FDA Pivotal-Study Feedback for Novel Neoadjuvant Therapy in Non-Muscle Invasive Bladder Cancer 4,75 SEK | +13,10% | 2,08 MSEK

2025-11-05 14:00:00 Hamlet BioPharma AB (publ): Klinisk studie på spädbarn bekräftar Hamlet BioPharmas strategi för icke-antibiotisk behandling av infektioner 4,37 SEK | -2,13% | 1,46 MSEK

2025-11-05 14:00:00 Hamlet BioPharma AB (publ): Clinical study in infants with febrile kidney infection supports Hamlet BioPharma's strategy for non-antibiotic treatment of bacterial infections 4,37 SEK | -2,13% | 1,46 MSEK

2025-11-04 12:30:00 Hamlet BioPharma AB (publ): KALLELSE TILL ÅRSSTÄMMA I HAMLET BIOPHARMA AB 4,46 SEK | -5,00% | 0,74 MSEK

2025-10-31 09:00:00 Hamlet BioPharma AB (publ): Hamlet BioPharma publicerar årsredovisning 2024/2025 4,83 SEK | -0,62% | 0,41 MSEK

2025-10-24 16:10:00 Hamlet BioPharma AB (publ): Clinical studies paving the way for non-antibiotic treatments of bacterial infections; details from the large-scale international study in infants 5,19 SEK | +7,01% | 0,74 MSEK

2025-10-24 16:10:00 Hamlet BioPharma AB (publ): A new approach to treating bacterial infections without antibiotics - targeting the disease response rather than the bacteria 5,19 SEK | +7,01% | 0,74 MSEK

2025-10-20 09:00:00 Hamlet BioPharma AB (publ): Hamlet Biopharma bjuder in till digitalt investerarmöte den 31 oktober 12.00 5,09 SEK | -1,17% | 0,09 MSEK

2025-10-01 09:50:00 Hamlet BioPharma AB (publ): Hamlet BioPharma presenterade vid Financial Stockholm-evenemanget den 29 september 2025 5,30 SEK | -5,02% | 0,50 MSEK

2025-09-23 09:00:00 Hamlet BioPharma AB (publ): Monthly investor meeting on the 25th of September 5,30 SEK | -0,93% | 1,24 MSEK

2025-09-22 13:53:14 Hamlet BioPharma AB (publ): Hamlet BioPharma prepares for next steps and secures drug manufacturing of Alpha1H at Phase III quality 5,35 SEK | -0,19% | 0,63 MSEK

2025-09-12 09:44:52 Hamlet BioPharma AB (publ): Riktad emission registrerad på Bolagsverket 5,68 SEK | -1,73% | 1,61 MSEK

2025-09-09 12:35:26 Hamlet BioPharma AB (publ): Hamlet BioPharma secures new patents to develop scientific discoveries into drugs for the treatment of cancer and infections 6,09 SEK | -0,98% | 1,43 MSEK

2025-09-04 10:38:37 Hamlet BioPharma AB (publ): Doctoral thesis to be defended today: Title `'Tumor response mechanisms and treatment effects of alpha1-oleate'' 6,01 SEK | -0,33% | 3,60 MSEK

2025-08-28 09:00:00 Hamlet BioPharma AB (publ): Year-end Report (Q4) July 2024 - June 2025 6,15 SEK | +4,59% | 3,43 MSEK

2025-08-27 14:20:58 Hamlet BioPharma AB (publ): Rättelse: Hamlet BioPharma bjuder in till pressträff torsdag 28 augusti 5,88 SEK | -0,34% | 1,12 MSEK

2025-08-27 11:39:34 Hamlet BioPharma AB (publ): Hamlet BioPharma bjuder in till pressträff den 28 augusti 5,88 SEK | -0,34% | 1,12 MSEK

2025-08-21 11:15:48 Hamlet BioPharma AB (publ): Hamlet BioPharma Announces the Completion of the Alpha1H Phase II Study in Non-Muscle Invasive Bladder Cancer 5,80 SEK | +6,62% | 3,72 MSEK

2025-08-11 12:09:57 Hamlet BioPharma AB (publ): Extra bolagsstämma beslutade godkänna styrelsens förslag om riktad nyemission för att finansiera fortsatt utveckling och kommersialisering baserad på tre positiva Fas II studier 5,24 SEK | +0,19% | 0,90 MSEK

2025-07-24 12:36:09 Hamlet BioPharma AB (publ): Hamlet BioPharma bjuder in till pressträff den 25 juli 4,82 SEK | +5,02% | 1,14 MSEK

2025-07-24 11:50:42 Kallelse till extra bolagsstämma i Hamlet BioPharma AB (publ) 4,82 SEK | +5,02% | 1,14 MSEK

2025-07-18 14:58:55 Hamlet BioPharma AB (publ): Hamlet BioPharma proposes a directed new share issue to finance continued development and commercialization based on three positive Phase II studies 4,00 SEK | -29,82% | 12,3 MSEK

2025-07-18 14:58:55 Hamlet BioPharma AB (publ): Hamlet BioPharma föreslår riktad nyemission för att finansiera fortsatt utveckling och kommersialisering baserat på tre positiva Fas II studier 4,00 SEK | -29,82% | 12,3 MSEK

2025-06-25 15:50:00 Hamlet BioPharma AB (publ): Hamlet BioPharma Holds Successful In Person Meeting with US FDA 4,18 SEK | +13,13% | 1,48 MSEK

2025-06-17 14:06:45 Hamlet BioPharma AB (publ): Hamlet BioPharma announces progress in Tuberculosis therapy 3,89 SEK | +2,50% | 0,42 MSEK

2025-06-17 10:00:00 Hamlet BioPharma AB (publ): Hamlet BioPharma invites to investor meeting on the 18th of June 3,89 SEK | +2,50% | 0,42 MSEK

2025-05-22 09:00:00 Hamlet BioPharma AB (publ): Q3 INTERIM REPORT JANUARY - MARCH 2025 4,04 SEK | +5,06% | 0,36 MSEK

2025-05-21 10:00:00 Hamlet BioPharma AB (publ): Hamlet BioPharma bjuder in till pressträff den 22 maj 3,85 SEK | -3,75% | 0,25 MSEK

2025-05-19 13:21:08 Hamlet BioPharma AB (publ): Scientific Breakthrough in Alpha1H's Mechanism of Action 4,00 SEK | +0,50% | 0,66 MSEK

2025-05-19 13:21:08 Hamlet BioPharma AB (publ): Vetenskapligt genombrott för Alpha1H:s verkningsmekanism i blåscancer 4,00 SEK | +0,50% | 0,66 MSEK

2025-05-02 11:26:30 Hamlet BioPharma AB (publ): Hamlet BioPharma presenterar framgångsrika prekliniska och kliniska data för Alpha1H vid AACR 2025 - stärker positionen inom behandling av blåscancer 4,29 SEK | +2,63% | 0,52 MSEK

2025-04-22 14:38:16 Hamlet BioPharma AB (publ): Hamlet BioPharma invites to investor meeting on the 23rd of April 4,46 SEK | +3,72% | 0,82 MSEK

2025-04-08 09:52:14 Hamlet BioPharma AB (publ): New scientific advances for Alpha1H highlight the unique discovery pipeline and drug development potential for the treatment of bladder cancer 4,10 SEK | 0,00% | 1,19 MSEK

2025-04-07 16:57:08 Hamlet BioPharma AB (publ): New granted patents added to Hamlet BioPharma's extensive patent portfolio in cancer and infection 4,10 SEK | +12,64% | 1,19 MSEK

↑	Select newer press release
↓	Select older press release
←	Navigate backwards
→	Navigate forward
Enter	Navigate to line in focus
Tab	Focus next link
A or 1	Open First attachment
S or 2	Open Second attachment
D or 3	Open Third attachment
F or 4	Open Fourth attachment
I	Show company information
PgUp	Select newest press release
PgDown	Select oldest press release
L	Focus on filer bar
N	Increase preview window size
M	Decrease preview window size
Esc	Escape from mode

Hamlet BioPharma

Språk

Typ

År

Språk

Typ

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden